RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BPTH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Bio-Path Holdings stock price up 1.98% on Thursday
(Updated on Mar 28, 2024)

Buy or Hold candidate since Feb 26, 2024 Loss -28.97% PDF

The Bio-Path Holdings stock price gained 1.98% on the last trading day (Thursday, 28th Mar 2024), rising from $4.04 to $4.12. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.73% from a day low at $4.01 to a day high of $4.24. The price has been going up and down for this period, and there has been a -22.77% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 35 thousand more shares were traded than the day before. In total, 46 thousand shares were bought and sold for approximately $189.87 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 359.64% during the next 3 months and, with a 90% probability hold a price between $13.61 and $37.24 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BPTH Signals & Forecast

The Bio-Path Holdings stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $4.14. On a fall, the stock will find some support from the long-term average at approximately $3.85. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Bio-Path Holdings has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 06, 2024, and so far it has fallen -36.02%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Bio-Path Holdings stock

Bio-Path Holdings finds support from accumulated volume at $4.04 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.230 between high and low, or 5.73%. For the last week, the stock has had daily average volatility of 16.22%.

Our recommended stop-loss: $3.85 (-6.46%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 16 days ago.)

Trading Expectations (BPTH) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Bio-Path Holdings to open at $4.12, and during the day (based on 14 day Average True Range), to move between $3.44 and $4.80, which gives a possible trading interval of +/-$0.677 (+/-16.44%) up or down from last closing price. If Bio-Path Holdings takes out the full calculated possible swing range there will be an estimated 32.88% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.04 (1.94%) than the resistance at $4.35 (5.58%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Bio-Path Holdings stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Bio-Path Holdings stock to perform well in the short-term.

Current score: 1.906 Buy Candidate Unchanged

Predicted Opening Price for Bio-Path Holdings of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$4.12 ( 0.0801%) $4.12

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BPTH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.35 5.66 %
R2 4.27 3.53 %
R1 4.21 2.21 %
Current price: 4.12
Support S1 4.04 -2.05 %
S2 3.98 -3.37 %
S3 3.89 -5.50 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.11 24.03 %
R2 4.86 17.96 %
R1 4.35 5.58 %
Current price 4.12
Support S1 4.04 -1.94%
S2 4.02 -2.43%
S3 3.78 -8.25%

FAQ

What is the symbol for Bio-Path Holdings Stock and on which exchange is it traded?
The symbol for Bio-Path Holdings is BPTH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bio-Path Holdings Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Bio-Path Holdings stock to perform well in the short-term.

How to buy Bio-Path Holdings Stock?
Bio-Path Holdings Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bio-Path Holdings Stock.

What's the current price of Bio-Path Holdings Stock?
As of the end of day on the 2024-03-28, the price of an Bio-Path Holdings (BPTH) share was $4.12.

What is the 52-week high and low for Bio-Path Holdings Stock?
The 52-week high for Bio-Path Holdings Stock is $7.50 and the 52-week low is $0.320.

What is the market capitalization of Bio-Path Holdings Stock?
As of the 2024-03-28, the market capitalization of Bio-Path Holdings is 2.797M.

When is the next earnings date for Bio-Path Holdings?
The upcoming earnings date for Bio-Path Holdings is May 10, 2024.
Click to get the best stock tips daily for free!

About Bio-Path Holdings

Bio-Path Holdings Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f... BPTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT